Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 19 | 2023 | 2237 | 1.610 |
Why?
|
Cystectomy | 6 | 2023 | 686 | 0.830 |
Why?
|
Vascular System Injuries | 1 | 2022 | 250 | 0.680 |
Why?
|
Kidney Neoplasms | 6 | 2024 | 4245 | 0.640 |
Why?
|
Nephrectomy | 5 | 2024 | 1049 | 0.610 |
Why?
|
Carcinoma, Renal Cell | 5 | 2024 | 3130 | 0.580 |
Why?
|
Surgical Instruments | 2 | 2022 | 395 | 0.500 |
Why?
|
Carcinoma, Transitional Cell | 4 | 2023 | 802 | 0.490 |
Why?
|
Urologic Surgical Procedures | 2 | 2014 | 302 | 0.460 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9230 | 0.410 |
Why?
|
Neoplasm Invasiveness | 11 | 2023 | 3614 | 0.390 |
Why?
|
Laparoscopy | 5 | 2024 | 2149 | 0.380 |
Why?
|
Nephrons | 1 | 2011 | 220 | 0.360 |
Why?
|
Postoperative Complications | 3 | 2021 | 15294 | 0.270 |
Why?
|
Salvage Therapy | 2 | 2021 | 1275 | 0.210 |
Why?
|
Transurethral Resection of Prostate | 1 | 2022 | 83 | 0.200 |
Why?
|
Renal Veins | 2 | 2019 | 108 | 0.190 |
Why?
|
MicroRNAs | 3 | 2012 | 3747 | 0.180 |
Why?
|
Equipment Failure | 1 | 2022 | 579 | 0.180 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2017 | 713 | 0.180 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 505 | 0.160 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1392 | 0.160 |
Why?
|
Prostate | 3 | 2022 | 1773 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2019 | 182 | 0.150 |
Why?
|
Urothelium | 2 | 2016 | 277 | 0.150 |
Why?
|
Prostatic Neoplasms | 4 | 2022 | 11074 | 0.150 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2010 | 2208 | 0.140 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2018 | 358 | 0.130 |
Why?
|
Phthalazines | 1 | 2018 | 363 | 0.130 |
Why?
|
Carcinoma | 2 | 2017 | 2375 | 0.130 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1583 | 0.130 |
Why?
|
Brachytherapy | 1 | 2022 | 1246 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1114 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8426 | 0.120 |
Why?
|
Treatment Outcome | 12 | 2024 | 63119 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1203 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 5 | 2017 | 6535 | 0.110 |
Why?
|
Gallbladder | 1 | 2014 | 301 | 0.110 |
Why?
|
Laparotomy | 1 | 2014 | 473 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8628 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1483 | 0.100 |
Why?
|
Humans | 34 | 2024 | 744220 | 0.100 |
Why?
|
Constriction | 1 | 2010 | 181 | 0.100 |
Why?
|
Warm Ischemia | 1 | 2010 | 53 | 0.090 |
Why?
|
Genes, Suppressor | 1 | 2010 | 48 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2078 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 933 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 412 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1256 | 0.090 |
Why?
|
Aged | 14 | 2023 | 163253 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2014 | 1184 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2013 | 895 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4752 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2024 | 77426 | 0.080 |
Why?
|
Databases, Factual | 1 | 2022 | 7730 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2948 | 0.070 |
Why?
|
Piperazines | 1 | 2018 | 2491 | 0.070 |
Why?
|
Prostatectomy | 1 | 2016 | 1887 | 0.070 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2009 | 472 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2016 | 1540 | 0.070 |
Why?
|
BCG Vaccine | 2 | 2023 | 368 | 0.070 |
Why?
|
Male | 15 | 2023 | 350027 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2009 | 638 | 0.070 |
Why?
|
Length of Stay | 2 | 2022 | 6308 | 0.070 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1365 | 0.070 |
Why?
|
Vena Cava, Inferior | 1 | 2008 | 436 | 0.070 |
Why?
|
Prognosis | 4 | 2020 | 29050 | 0.060 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2010 | 789 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3921 | 0.060 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2422 | 0.060 |
Why?
|
Neoplasm Staging | 4 | 2017 | 11007 | 0.060 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2023 | 105 | 0.060 |
Why?
|
Triacetoneamine-N-Oxyl | 1 | 2022 | 5 | 0.060 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9438 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2170 | 0.050 |
Why?
|
Thrombectomy | 1 | 2008 | 679 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2020 | 11478 | 0.050 |
Why?
|
Female | 11 | 2023 | 380197 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2848 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18027 | 0.050 |
Why?
|
Transcription Factors | 2 | 2012 | 12207 | 0.050 |
Why?
|
Robotics | 1 | 2009 | 899 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2013 | 2726 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4216 | 0.050 |
Why?
|
Liver | 2 | 2014 | 7472 | 0.050 |
Why?
|
Lymphatic Metastasis | 2 | 2020 | 2914 | 0.050 |
Why?
|
Urethra | 1 | 2022 | 408 | 0.050 |
Why?
|
Middle Aged | 10 | 2020 | 213367 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6893 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2022 | 2478 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 564 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2018 | 16687 | 0.040 |
Why?
|
Muscles | 1 | 2023 | 1622 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3703 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6313 | 0.040 |
Why?
|
Cisplatin | 1 | 2023 | 1642 | 0.040 |
Why?
|
beta Catenin | 1 | 2022 | 1059 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2023 | 1172 | 0.040 |
Why?
|
Prospective Studies | 3 | 2023 | 53280 | 0.040 |
Why?
|
Propensity Score | 1 | 2023 | 1781 | 0.030 |
Why?
|
Computer Simulation | 1 | 2009 | 6196 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2017 | 57768 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12956 | 0.030 |
Why?
|
United States | 1 | 2022 | 69867 | 0.030 |
Why?
|
Anastomotic Leak | 1 | 2016 | 162 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12781 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35423 | 0.030 |
Why?
|
Adult | 6 | 2017 | 214035 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11368 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9311 | 0.030 |
Why?
|
Cholic Acids | 1 | 2013 | 40 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 594 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3689 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10949 | 0.030 |
Why?
|
Administration, Intravesical | 1 | 2013 | 91 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10480 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12244 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4841 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2022 | 12961 | 0.030 |
Why?
|
Disaccharides | 1 | 2013 | 172 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 749 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12355 | 0.030 |
Why?
|
Neurodegenerative Diseases | 1 | 2001 | 1062 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 661 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2001 | 1708 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2019 | 19907 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 729 | 0.030 |
Why?
|
tau Proteins | 1 | 2001 | 1868 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2013 | 892 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 56436 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13280 | 0.020 |
Why?
|
Survival Analysis | 2 | 2013 | 10250 | 0.020 |
Why?
|
Cell Cycle | 1 | 2018 | 2967 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 2008 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2016 | 1195 | 0.020 |
Why?
|
Animals | 4 | 2020 | 168788 | 0.020 |
Why?
|
Adenoviridae | 1 | 2013 | 1099 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 553 | 0.020 |
Why?
|
Lipocalins | 1 | 2009 | 170 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2009 | 262 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2010 | 411 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1731 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5881 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5722 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2619 | 0.020 |
Why?
|
Renal Artery | 1 | 2008 | 398 | 0.020 |
Why?
|
Survivors | 1 | 2017 | 2291 | 0.020 |
Why?
|
Risk Factors | 3 | 2017 | 72280 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 40063 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3520 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4929 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9728 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 2008 | 1066 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2013 | 3420 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6612 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5180 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5076 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 9335 | 0.010 |
Why?
|
Neuropil | 1 | 2001 | 30 | 0.010 |
Why?
|
Nerve Endings | 1 | 2001 | 109 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2012 | 3023 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12801 | 0.010 |
Why?
|
Vacuoles | 1 | 2001 | 230 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9392 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18116 | 0.010 |
Why?
|
Preoperative Care | 1 | 2008 | 2246 | 0.010 |
Why?
|
Acetylcholine | 1 | 2001 | 621 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1238 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20945 | 0.010 |
Why?
|
Neurofibrillary Tangles | 1 | 2001 | 439 | 0.010 |
Why?
|
Cell Movement | 1 | 2010 | 5216 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 13036 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13409 | 0.010 |
Why?
|
Mutation | 2 | 2018 | 29784 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14726 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4553 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2001 | 748 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2001 | 1549 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39045 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23404 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15070 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81178 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23337 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13668 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8437 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 85759 | 0.000 |
Why?
|
Aging | 1 | 2001 | 8661 | 0.000 |
Why?
|
Brain | 1 | 2001 | 26413 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_